A novel co-targeting strategy of EGFR/SEC61G for multi-modality fluorescence/MR/photoacoustic imaging of glioblastoma.

[1]  W. Stummer,et al.  5-ALA and FDA approval for glioma surgery , 2019, Journal of Neuro-Oncology.

[2]  F. Kang,et al.  A novel plectin/integrin-targeted bispecific molecular probe for magnetic resonance/near-infrared imaging of pancreatic cancer. , 2018, Biomaterials.

[3]  C. Decristoforo,et al.  Molecular Imaging: In Vivo Agents for the Diagnosis and Treatment of Cancer , 2018, Contrast media & molecular imaging.

[4]  Yun Li,et al.  Oncogenic DIRAS3 promotes malignant phenotypes of glioma by activating EGFR-AKT signaling. , 2018, Biochemical and biophysical research communications.

[5]  C. Hadjipanayis,et al.  Fluorescence‐guided surgery for high‐grade gliomas , 2018, Journal of surgical oncology.

[6]  A. Bruselles,et al.  Novel SEC61G-EGFR Fusion Gene in Pediatric Ependymomas Discovered by Clonal Expansion of Stem Cells in Absence of Exogenous Mitogens. , 2017, Cancer research.

[7]  Linton T. Evans,et al.  Simultaneous In Vivo Fluorescent Markers for Perfusion, Protoporphyrin Metabolism, and EGFR Expression for Optically Guided Identification of Orthotopic Glioma , 2016, Clinical Cancer Research.

[8]  Jie Tian,et al.  Near-infrared dye-loaded magnetic nanoparticles as photoacoustic contrast agent for enhanced tumor imaging , 2016, Cancer biology & medicine.

[9]  Feiyifan Wang,et al.  Sample Level Enrichment Analysis of KEGG Pathways Identifies Clinically Relevant Subtypes of Glioblastoma , 2016, Journal of Cancer.

[10]  A. Sloan,et al.  Fluorescent-Guided Surgical Resection of Glioma with Targeted Molecular Imaging Agents: A Literature Review. , 2016, World neurosurgery.

[11]  Yu Wang,et al.  CGCG clinical practice guidelines for the management of adult diffuse gliomas. , 2016, Cancer letters.

[12]  G. Reifenberger,et al.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary , 2016, Acta Neuropathologica.

[13]  Y. Chen,et al.  Dual‐Targeting Lactoferrin‐Conjugated Polymerized Magnetic Polydiacetylene‐Assembled Nanocarriers with Self‐Responsive Fluorescence/Magnetic Resonance Imaging for In Vivo Brain Tumor Therapy , 2016, Advanced healthcare materials.

[14]  Jen-Hung Fang,et al.  Magnetic Core–Shell Nanocapsules with Dual‐Targeting Capabilities and Co‐Delivery of Multiple Drugs to Treat Brain Gliomas , 2014, Advanced healthcare materials.

[15]  D. Haussler,et al.  The Somatic Genomic Landscape of Glioblastoma , 2013, Cell.

[16]  Z. Dai,et al.  Indocyanine green loaded SPIO nanoparticles with phospholipid-PEG coating for dual-modal imaging and photothermal therapy. , 2013, Biomaterials.

[17]  Vasilis Ntziachristos,et al.  Multispectral Opto-acoustic Tomography (MSOT) of the Brain and Glioblastoma Characterization , 2013, NeuroImage.

[18]  G. Kao,et al.  Stereotactic intracranial implantation and in vivo bioluminescent imaging of tumor xenografts in a mouse model system of glioblastoma multiforme. , 2012, Journal of visualized experiments : JoVE.

[19]  Leonhard Möckl,et al.  Tuning nanoparticle uptake: live-cell imaging reveals two distinct endocytosis mechanisms mediated by natural and artificial EGFR targeting ligand. , 2012, Nano letters.

[20]  Benjamin E. Gross,et al.  The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.

[21]  Sanjiv S Gambhir,et al.  A molecular imaging primer: modalities, imaging agents, and applications. , 2012, Physiological reviews.

[22]  J. Gillard,et al.  Imaging biomarkers of brain tumour margin and tumour invasion. , 2011, The British journal of radiology.

[23]  Volker Seifert,et al.  Intraoperative MRI guidance and extent of resection in glioma surgery: a randomised, controlled trial. , 2011, The Lancet. Oncology.

[24]  Xin Gao,et al.  Dual docetaxel/superparamagnetic iron oxide loaded nanoparticles for both targeting magnetic resonance imaging and cancer therapy. , 2011, Biomaterials.

[25]  Gang Bao,et al.  Coating optimization of superparamagnetic iron oxide nanoparticles for high T2 relaxivity. , 2010, Nano letters.

[26]  Oren Sagher,et al.  The Brain Tumor Window Model: A Combined Cranial Window and Implanted Glioma Model for Evaluating Intraoperative Contrast Agents , 2010, Neurosurgery.

[27]  Arya Nabavi,et al.  FIVE‐AMINOLEVULINIC ACID FOR FLUORESCENCE‐GUIDED RESECTION OF RECURRENT MALIGNANT GLIOMAS: A PHASE II STUDY , 2009, Neurosurgery.

[28]  R. McLendon,et al.  Glioblastoma proto-oncogene SEC61gamma is required for tumor cell survival and response to endoplasmic reticulum stress. , 2009, Cancer research.

[29]  Morag Park,et al.  Breakdown of endocytosis in the oncogenic activation of receptor tyrosine kinases. , 2009, American journal of physiology. Endocrinology and metabolism.

[30]  Henry Brem,et al.  Independent association of extent of resection with survival in patients with malignant brain astrocytoma. , 2009, Journal of neurosurgery.

[31]  Joshua M. Korn,et al.  Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2008, Nature.

[32]  M. Berger,et al.  GLIOMA EXTENT OF RESECTION AND ITS IMPACT ON PATIENT OUTCOME , 2008, Neurosurgery.

[33]  Guido Gerig,et al.  User-guided 3D active contour segmentation of anatomical structures: Significantly improved efficiency and reliability , 2006, NeuroImage.

[34]  F. Zanella,et al.  Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. , 2006, The Lancet. Oncology.

[35]  T. Krings,et al.  Course of brain shift during microsurgical resection of supratentorial cerebral lesions: limits of conventional neuronavigation , 2004, Acta Neurochirurgica.

[36]  H. Maeda,et al.  Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[37]  Jill S Barnholtz-Sloan,et al.  CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014 , 2017, Neuro-oncology.

[38]  Chengyuan Feng,et al.  EGFL7 is an intercellular EGFR signal messenger that plays an oncogenic role in glioma. , 2017, Cancer letters.

[39]  Jeannine Walston,et al.  ABOUT THE AMERICAN BRAIN TUMOR ASSOCIATION , 2014 .

[40]  N. Düzgüneş,et al.  Efficient gene delivery by EGF-lipoplexes in vitro and in vivo. , 2011, Nanomedicine.

[41]  Tanja Woyke,et al.  Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets. , 2005, Neoplasia.